These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1704122)

  • 21. [Use of Getah virus for antiviral assay of human interferon].
    Ogiso S; Shirai J; Tuchiya Y; Honda E
    Uirusu; 2005 Dec; 55(2):317-26. PubMed ID: 16557019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bovine type II interferon: activity in heterologous cells.
    Babiuk LA; Rouse BT
    Intervirology; 1977; 8(4):250-6. PubMed ID: 194868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of detectable serum interferon in acute and chronic viral hepatitis.
    Pirovino M; Aguet M; Huber M; Altorfer J; Schmid M
    Hepatology; 1986; 6(4):645-7. PubMed ID: 2426168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentration of heterogeneous leukocyte interferon].
    Solov'ev VD; Parfenov VV; Zubanova NA; Pokidysheva LN; Tkach TA
    Vopr Virusol; 1981; (6):720-4. PubMed ID: 6175114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral effect of interferon covalently bound to sepharose.
    Ankel H; Chany C; Galliot B; Chevalier MJ; Robert M
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2360-3. PubMed ID: 4365374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of the serum inhibitory factor on interferon induction in chronic active hepatitis].
    Tang SB
    Zhonghua Nei Ke Za Zhi; 1983 Mar; 22(3):159-61. PubMed ID: 6191928
    [No Abstract]   [Full Text] [Related]  

  • 27. Purification of human fibroblast interferon prepared in the absence of serum.
    Knight E
    Methods Enzymol; 1981; 78(Pt A):417-21. PubMed ID: 6173623
    [No Abstract]   [Full Text] [Related]  

  • 28. Relative antiviral resistance induced in homologous and heterologous cells by cross-reacting interferons.
    Stewart WE; Lockart RZ
    J Virol; 1970 Dec; 6(6):795-9. PubMed ID: 4322082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A PERSPECTIVE CULTURAL MODEL FOR CONTROL OF BIOLOGICAL ACTIVITY OF HUMAN INTERFERONS].
    Nagieva FG; Barkova EP; Fedotov AY; Gaiderova LA; Lisakov AN; Nochevny VT
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):39-44. PubMed ID: 26829852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations.
    Gresser I; Brouty-Boyé D; Thomas MT; Macieira-Coelho A
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1052-8. PubMed ID: 4319881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differences in the antiviral and antioncogenic action of interferons produced in murine peritoneal cells and in Krebs-2 ascitic carcinoma cells].
    Marchenko VI; Pokidysheva LN; Malinovskaia VV; Aliab'eva TI; Khesin IaE
    Vopr Virusol; 1977; (3):344-8. PubMed ID: 198969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of cell-bound interferon.
    Stewart WE; De Clercq E; De Somer P
    J Virol; 1972 Oct; 10(4):707-12. PubMed ID: 4343547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity in interferon-treated bovine tracheal organ cultures.
    Fulton RW; Root SK
    Infect Immun; 1978 Aug; 21(2):672-3. PubMed ID: 211089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of human interferon from lymphoblastoid (Namalva) cultures.
    Zoon KC
    Methods Enzymol; 1981; 78(Pt A):457-64. PubMed ID: 6173629
    [No Abstract]   [Full Text] [Related]  

  • 35. Production, purification, and characterization of rat interferon from transformed rat cells.
    van der Meide PH; Wubben J; Vijverberg K; Schellekens H
    Methods Enzymol; 1986; 119():220-30. PubMed ID: 2429144
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interferon status in predicting the outcome of acute viral hepatitis B].
    Malinovskaia VV; Neumoina MV; Budanov SB
    Vopr Virusol; 1995; 40(4):174-7. PubMed ID: 7483570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.
    Geber WF; Lefkowitz SS; Hung CY
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):322-7. PubMed ID: 50766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay of interferon by reduction of viral RNA synthesis: a convenient assay for tracer experiments with monolayer cultures.
    Suzuki J; Iizuka M; Kobayashi S
    Methods Enzymol; 1981; 78(Pt A):403-9. PubMed ID: 6173621
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of interferon inducers in treating viral diseases].
    Frolov AF; Vovk AD; Diadon ST; Dziublik IV; Trinus EK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):58-62. PubMed ID: 6207690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change in interferon status in patients with acute viral hepatitis during intramuscular and rectal administration of genetically engineered alpha-2-interferon].
    Malinovskaia VV; Neumoina MV; Budanov SV
    Vopr Virusol; 1994; 39(6):269-72. PubMed ID: 7536374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.